Gupta, R. (2020). Pharmacovigilance of biosimilars - Why is it different from generics and innovator biologics? J Postgrad Med.
Chicago Stili AlıntıGupta, Ranjan. "Pharmacovigilance of Biosimilars - Why Is It Different From Generics and Innovator Biologics?" J Postgrad Med 2020.
MLA AlıntıGupta, Ranjan. "Pharmacovigilance of Biosimilars - Why Is It Different From Generics and Innovator Biologics?" J Postgrad Med 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..